Novavax (NVAX) Interest Expenses (2010 - 2026)
Novavax (NVAX) reported Interest Expenses of $5.69 million for Q2 2026, up 3.1% from $5.52 million a year earlier and up 16.1% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Interest Expenses (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Novavax's Interest Expenses came in at $21.9 million, down 5.1% year-over-year; for FY2025, it was $22.55 million, up 12.3% from FY2024.
- Interest Expenses has a five-year compound annual growth rate of 8.3% (FY2020 to FY2025).
- By year, Interest Expenses came in at $20.08 million in FY2024 (+39.3%), $14.42 million in FY2023 (-27.5%), $19.88 million in FY2022 (-5.9%) and $21.13 million in FY2021 (+39.5%).
- Five-year quarterly Interest Expenses spans a low of $2.86 million in Q3 2023 and a high of $7.59 million in Q4 2024.
- Year over year, Interest Expenses gained in six of the last eight quarters, with growth averaging 25.0%.
- The high point for year-over-year Interest Expenses in five years was Q4 2024 (growth of 84.2%); the low point was Q2 2023 (a decline of 49.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.9 million (Q1 2026), $5.82 million (Q4 2025) and $5.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Novavax | 1.78 Bn | -1.23 Bn | 42.45 Mn | 5.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.69 Mn |
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 5.82 Mn |
| Sep 30, 2025 | 5.48 Mn |
| Jun 30, 2025 | 5.52 Mn |
| Mar 31, 2025 | 5.72 Mn |
| Dec 31, 2024 | 7.59 Mn |
| Sep 30, 2024 | 4.24 Mn |
| Jun 30, 2024 | 4.14 Mn |
| Mar 31, 2024 | 4.11 Mn |
| Dec 31, 2023 | 4.12 Mn |
| Sep 30, 2023 | 2.86 Mn |
| Jun 30, 2023 | 3.12 Mn |
| Mar 31, 2023 | 4.32 Mn |
| Dec 31, 2022 | 4.60 Mn |
| Sep 30, 2022 | 4.17 Mn |
| Jun 30, 2022 | 6.23 Mn |
| Mar 31, 2022 | 4.88 Mn |
| Dec 31, 2021 | 5.14 Mn |
| Sep 30, 2021 | 5.18 Mn |
API Access
Novavax Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();